News Makers 2015

- archived News Makers -
  • 11 - 29 - 15

    Even In Your 20s, Fitness Cuts Risk for Later Heart Disease, Major Study Finds

    Ira S. Ockene, MD, professor of medicine, comments on a new study that show how remaining active in young adulthood and reducing sedentary time can improve cardiovascular health.
    WBUR CommonHealth
    Medical News Today
    Huffington Post

  • 11 - 29 - 15

    Exercise as young adult tied to heart health decades later

    Ira S. Ockene, MD, professor of medicine, comments on a new study that show how remaining active in young adulthood and reducing sedentary time can improve cardiovascular health.

    Fox News

    Medical Xpress

  • 11 - 29 - 15

    Ghosts in the Genome

    Oliver Rando, ME, PhD, professor of biochemistry and molecular pharmacology, explains the role epigenetics plays in offspring inheriting certain characteristics from their parents.
    The Scientist

  • 11 - 29 - 15

    Study says taking tobacco off displays may work

    Joseph DiFranza, MD, professor of family medicine and community health, comments on a new study that suggests keeping tobacco products out of sight in convenience stores may make teens less likely to smoke.

  • 11 - 29 - 15

    Summit opens debate on ethics of gene editing

    An article about the gene editing summit being held in Washington D.C. references a recent study by the University of Massachusetts Medical School which used a CRISPR technique to switch off, rather than cut and repair, a gene in muscle cells that causes one form of muscular dystrophy.
    Los Angeles Times
    NBC News

  • 11 - 28 - 15

    AS I SEE IT: Bringing awareness to men's health issues

    Mitchell H. Sokoloff, MD, FACS, professor and chair of urology, calls attention to the need for increased awareness about men’s health issues.
    Worcester Telegram & Gazette

  • 11 - 28 - 15

    Large, 'innovative' veterans clinic in Worcester is a no-go; UMass envisions smaller site

    Plans for a new Veterans Affairs clinic at UMass Medical School has been reduced in scope by the federal government.
    Worcester Telegram & Gazette

  • 11 - 26 - 15

    A vibrating mattress could ease sleep in infants

    Led by David Paydarfar, MD, professor and vice chair of neurology, a team of scientists and clinicians at UMass Medical School, the Wyss Institute for Biologically Inspired Engineering and the Beth Israel Deaconess Medical Center, have shown in a clinical trial that a new vibration-based prevention technology reduces apneic events in prematurely born infants.
    Beta Boston

  • 11 - 24 - 15

    Delay in funding for life sciences worries scientists in Massachusetts

    An article about potential delays in funding for the Massachusetts Life Sciences Center references investments made at UMass Medical School, including the cryo-electron microscope.

  • 11 - 24 - 15

    Two Valuable Treatment Advances in Rheumatoid Arthritis

    Jonathan Kay, MD, professor of medicine, reports from the 2015 American College of Rheumatology Annual Scientific Meeting about new research that shows that a low multibiomarker disease activity score for early rheumatoid arthritis allows for better response to triple therapy.

  • 11 - 22 - 15

    Central Mass. to benefit from Life Sciences 2.0

    UMass Medical School is at the center of a growing biomanufacturing initiative in Worcester and is key to providing access to top-tier resources not available elsewhere according to a recent article about the next phase of investment for the Massachusetts Life Sciences Center. 
    Worcester Business Journal

  • 11 - 22 - 15

    The Trip Planners

    Toxicologist Edward Boyer, MD, PhD, professor of emergency medicine, explains how Erowid, repository of drug-culture esoterica on the Internet, changed how toxicologists learn the street names of unfamiliar drugs, along with the basic chemicals that they contained.
    The New Yorker

  • 11 - 22 - 15

    VA wait times improving in Central Mass., but much ground left to go

    An article about excessive wait times experienced by Central Massachusetts veterans seeking health care includes comments from Veterans Affairs Central Western Massachusetts Healthcare System Director John P. Collins regarding his support for a partnership with UMass Medical School proposed in 2014. 
    Worcester Telegram & Gazette

  • 11 - 22 - 15

    Vibration-based technology reduces apneic events, improves critical clinical parameters in premature infants

    David Paydarfar, MD, professor and vice chair of neurology, has developed a vibration-based prevention technology that has been shown to reduce apneic events in a neonatal intensive care unit (NICU) and improves critical clinical parameters in prematurely born infants.

  • 11 - 19 - 15

    Researchers identify molecular link between schizophrenia and diabetes risk

    Rita Bortell, PhD, research professor of molecular medicine, and Agata Jurczyk, PhD, instructor in molecular medicine, have discovered that a shared gene (or genes) may underlie the co-occurrence of schizophrenia and diabetes.
    Boston Globe

  • 11 - 19 - 15

    Seat belt enforcement bill again pitched as life-saver

    Michael P. Hirsh, MD, professor of pediatric surgery, chief of pediatric surgery & trauma and Worcester’s interim commissioner of public health, advocates that  lawmakers support a bill that would allow police officers to pull over drivers for not wearing seat belts.
    State House News Service

  • 11 - 19 - 15

    Stemming the opioid crisis

    An op-ed by Chancellor Michael Collins, MD, discusses how Massachusetts is combatting the opioid crisis and the role UMass Medical School plays in that fight.
    Worcester Telegram and Gazette

  • 11 - 18 - 15

    New technique improves accuracy of CRISPR/Cas9 gene editing system

    Scot Wolfe, PhD, associate professor of molecular, cell & cancer biology, has developed a new CRISPR technology that is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.

  • 11 - 18 - 15

    UMass researchers achieve several ‘firsts’ in new use for CRISPR/Cas9

    Research associate Charis Himeda talks to the BBJ about a new technique for turning off genes that cause a rare form of muscular dystrophy.
    Washington Post
    Boston Business Journal

  • 11 - 16 - 15

    HCV Combo Tx Shows Wide Efficacy

    Gyongyi Szabo, MD, PhD, professor of medicine, is quoted in an article about a promising investigational drug combination being used to treat patients with hepatitis C.
    MedPage Today

  • 11 - 16 - 15

    In Worcester, state launches health options call network

    Joyce A. Murphy, MPA, executive vice chancellor of UMass Medical School’s Commonwealth Medicine division, is quoted in an article about the newly opened MassOptions, which connects elders, individuals with disabilities and their caregivers with agencies and organizations that can best meet their needs. 
    Worcester Telegram & Gazette

  • 11 - 15 - 15

    UMass medical students train to treat, prevent opioid abuse

    Chancellor Michael Collins, MD, announced that it is immediately incorporating into its School of Medicine curriculum specific training in support of 10 agreed-upon core competencies for the prevention and management of prescription drug misuse.
    Boston Globe

  • 11 - 14 - 15

    Improve star ratings by focusing on MTM

    Bonnie Greenwood, PharmD, BCPS, clinical program director of clinical pharmacy services, writes about how health plans can raise their Centers for Medicare and Medicaid Services (CMS) Star Ratings.
    Modern Medicine

  • 11 - 12 - 15

    It’s Not Just Heroin: Drug Cocktails Are Fueling The Overdose Crisis

    Kavita Babu, a toxicologist and associate professor of emergency medicine, describes the risks of prescribing medications in combination with an opiate and what physicians can do to minimize adverse interactions.

  • 11 - 12 - 15

    Merck & Co. weeks away from filing first antibacterial mAb

    Bezlotoxumab, a fully-human monoclonal antibody, developed by researchers at the University of Massachusetts Medical School’s MassBiologics with Medarex (now part of Bristol-Myers Squibb), and licensed to Merck in 2009 is nearing FDA approval.
    BioPharma Reporter

  • 11 - 09 - 15

    Wearable Devices Impact Heart Health Remote Monitoring

    David McManus, MD, associate professor of medicine, and colleagues are working on ways to remotely and noninvasively monitor patients with serious cardiac disease in the hopes of keeping them healthier and preventing emergency room visits and hospitalizations.
    mHealth Intelligence

  • 11 - 08 - 15

    Sensing Danger: Technology Aims to Combat Opioid Crisis

    Stephanie Carreiro, MD, instructor in emergency medicine, explains how a wrist bracelet now being tested at UMMS can be used to help treat recovering addicts.

  • 11 - 02 - 15

    UMass Medical Test Confirms Diversity in Medicine Is Still Lacking

    A new survey developed by UMass Medical School (UMMS) and The Association of American Medical Colleges is being used to assess diversity in academic medical centers across the country.
    Boston Magazine

  • 11 - 01 - 15

    Lots of Houses, Nobody Home; Rural Scholars Report on Homeless Study

    A survey designed by a group of eight students from the University of Massachusetts Medical School Rural Health Scholars program is intended to help Dukes County quantify the homeless population on the Island.
    Vineyard Gazette
    Martha's Vineyard Times

  • 11 - 01 - 15

    Lyme disease antibody eyed

    Mark Klempner, MD, executive vice chancellor for MassBiologics and professor of medicine, explains how scientists at MassBiologics are developing a pre-exposure prophylaxis that prevents tick-transmitted infection of Lyme disease, a breakthrough that could lead to seasonal prevention against the most common tick-borne infection in North America.
    Boston Globe